BioHealth News Archive
Measuring the return from pharmaceutical innovation 2018 – Deloitte UK
The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began…
Read MoreBioHealth Trade Mission to the United Kingdom Midlands – 3/5/2019 – Maryland
The Maryland Department of Commerce is seeking BioHealth companies with an interest in participating in a trade mission to the United Kingdom hosted by…
Read MoreUMB licences potential prostate cancer treatment to startup – Maryland Daily Record
The University of Maryland, Baltimore has granted Educational & Scientific, LLC an exclusive license with the potential to treat prostate cancer, UM Ventures announced…
Read MoreBiotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved | Benzinga
Health care stocks are among a handful of sectors bucking the broader market downturn in 2018. Biotechs, though down for the year, have suffered…
Read MoreUMB inks second licensing deal with spinout developing cancer treatments – Technical.ly Baltimore
A startup developing new cancer treatments recently signed its second tech transfer deal with the University of Maryland, Baltimore. {iframe}https://technical.ly/baltimore/2018/12/19/umb-licenses-second-cancer-treatment-technology-to-spinout/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=68495737&_hsenc=p2ANqtz--lbmG1ZdOu_KHCwePzBbsS6nQNeVcjHB84-lutbB-GyvO5-CBOYBaG79RwmwdojMMjfPcGnjE4ggxWhbeCWw82BDj1nA&_hsmi=68495737{/iframe}
Read MoreReGelTec, led by former Harpoon Medical executives, raises $2M – Technical.ly Baltimore
After leading Harpoon Medical to a $100 million acquisition by Edwards Lifesciences last year, CEO Bill Niland and three other executives are now working on a…
Read MoreJ. Craig Venter Wins Dismissal of Lawsuit by Company He Co-Founded | Articles | ClinicalOMICs
The research institute founded and headed by J. Craig Venter, Ph.D., yesterday won the dismissal of a federal lawsuit filed against it by the…
Read MoreGE files paperwork for IPO of health-care unit
General Electric has filed paperwork for an IPO of its health-care unit, GE Healthcare, according to people familiar with the matter. GE is working…
Read MoreState Technology and Science Index
State Tech and Science Index - 2018 {iframe}http://statetechandscience.org/statetech.taf?page=map&show=top{/iframe}
Read MoreTop 10 RNA-Based Biopharmas of 2018
It wouldn’t be a stretch to call 2018 the year RNA-based treatments, such as those applying RNA interference (RNAi) or small interfering RNA (siRNA),…
Read MoreEmergent BioSolutions Receives Health Canada Approval of BioThrax® (Anthrax Vaccine Adsorbed)
Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its anthrax vaccine, BioThrax® (Anthrax Vaccine…
Read More39 years and counting: Johns Hopkins again leads country in R&D spending – Baltimore Business Journal
A large chunk of the school's research spending — about $1.5 billion — can be attributed to Hopkins' Applied Physics Laboratory, based in Laurel.…
Read MoreEversense CGM Wins a 2018 “Best of What’s New” Award – Senseonics
Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)…
Read MoreMaryland Stem Cell Research Consortium Funding Opportunities – Deadline 1/17/19
The Maryland Stem Cell Research Fund provides a variety of grant programs for human stem cell research in the state of Maryland. Each RFA…
Read MoreEDUCATIONAL & SCIENTIFIC, LLC AND UNIVERSITY OF MARYLAND, BALTIMORE EXPAND RELATIONSHIP THROUGH LICENSING AGREEMENT TO DEVELOP NOVEL PROSTATE CANCER TREATMENT
University of Maryland (UM) Ventures and Educational & Scientific, LLC (ESL) announced today that the University of Maryland, Baltimore (UMB) has again granted ESL…
Read More